Trial Profile
REMission INDuction in very early Rheumatoid Arthritis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Golimumab (Primary) ; Methotrexate (Primary) ; Disease-modifying antirheumatics; Glucocorticoids; Hydroxychloroquine; Methylprednisolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms REMINDRA
- 25 Apr 2019 Status changed from recruiting to discontinued.
- 20 Mar 2017 Status changed from not yet recruiting to recruiting.
- 08 Oct 2016 New trial record